Factors to predict PFS in patients with WM treated with BTK inhibitors: iNNOVATE & ASPEN
Jorge Castillo • 29 Sep 2023
AUGMENT-ing treatment: lenalidomide plus rituximab for R/R indolent NHL
John Leonard • 17 Jan 2019
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.